BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li R, Tian F, Qi Y, Ma L, Zhou T, Li Y, Hui T, Zhang L, Wang S, Song Z. Pegylated liposomal doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant chemotherapy in locally advanced breast cancer (registration number: ChiCTR1900023052). Sci Rep 2019;9:18135. [PMID: 31792258 DOI: 10.1038/s41598-019-54387-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang H, Li Y, Qi Y, Zhao E, Kong X, Yang C, Yang Q, Zhang C, Liu Y, Song Z. Pegylated Liposomal Doxorubicin, Docetaxel, and Trastuzumab as Neoadjuvant Treatment for HER2-Positive Breast Cancer Patients: A Phase II and Biomarker Study. Front Oncol 2022;12:909426. [DOI: 10.3389/fonc.2022.909426] [Reference Citation Analysis]
2 Ren Y, Cui GD, He LS, Yao H, Zi CY, Gao YX. Traditional Uses, Phytochemistry, Pharmacology and Toxicology of Rhizoma phragmitis: A Narrative Review. Chin J Integr Med 2022. [PMID: 35319074 DOI: 10.1007/s11655-022-3572-1] [Reference Citation Analysis]
3 Zhang J, Jiang H, Zhang J, Bao G, Zhang G, Wang H, Wang X. Effectiveness and safety of pegylated liposomal doxorubicin versus epirubicin as neoadjuvant or adjuvant chemotherapy for breast cancer: a real-world study. BMC Cancer 2021;21:1301. [PMID: 34872507 DOI: 10.1186/s12885-021-09050-6] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Gil-Gil MJ, Bellet M, Bergamino M, Morales S, Barnadas A, Manso L, Saura C, Fernández-Ortega A, Garcia-Martinez E, Martinez-Jañez N, Melé M, Villagrasa P, Celiz P, Perez Martin X, Ciruelos E, Pernas S. Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Cancer. Final Results of the Multicentre Phase II CAPRICE Study. Front Oncol 2021;11:645026. [PMID: 34307126 DOI: 10.3389/fonc.2021.645026] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
5 Wang L, Hong Y, Ma J, Han M, Zhang S, Shan B, Liu Y. Combination of pegylated liposomal doxorubicin and docetaxel as neoadjuvant therapy for breast cancer with axillary lymph node metastasis. J Int Med Res 2020;48:300060520944310. [PMID: 32776809 DOI: 10.1177/0300060520944310] [Cited by in F6Publishing: 1] [Reference Citation Analysis]